KP1339 (CHEBI:176975)

ChEBI > Main

Main

ChEBI Ontology

Automatic Xrefs

Reactions

Pathways

Models

ChEBI Name	KP1339

ChEBI ID	CHEBI:176975

Definition	A ruthenium coordination entity that is the sodium salt of tetrachloro[bis(1H-indazole)]ruthenate(III). It is a anticancer drug in clinical development for the treatment of solid tumours.

Stars	This entity has been manually annotated by the ChEBI Team.

Submitter	Anonymous

Supplier Information

Download	Molfile XML SDF

Formula

C14H12Cl4N4Ru.Na

Net Charge

Average Mass

502.140

Monoisotopic Mass

500.87572

InChI

InChI=1S/2C7H6N2.4ClH.Na.Ru/c2*1-2-4-7-6(3-1)5-8-9-7;;;;;;/h2*1-5H,(H,8,9);4*1H;;/q;;;;;;+1;+3/p-4

InChIKey

WVVOCRYXBTVDRN-UHFFFAOYSA-J

SMILES

[Na+].Cl[Ru-3](Cl)(Cl)(Cl)([N+]1=CC2=C(N1)C=CC=C2)[N+]1=CC2=C(N1)C=CC=C2

Roles Classification
Biological Role(s):	apoptosis inducer Any substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms.

Application(s):	antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms.

ChEBI Ontology
Outgoing	KP1339 (CHEBI:176975) has role antineoplastic agent (CHEBI:35610) KP1339 (CHEBI:176975) has role apoptosis inducer (CHEBI:68495) KP1339 (CHEBI:176975) is a ruthenium coordination entity (CHEBI:35733)

IUPAC Name

sodium tetrachloro[bis(1H-indazole-κN²)]ruthenate(1−)

Synonyms	Sources
BOLD-100	SUBMITTER
IT-139	SUBMITTER
KP-1339	ChEBI
NKP-1339	SUBMITTER
sodium trans-[tetrachloridobis(1H-indazole)ruthenate(III)]	ChEBI

Registry Number	Type	Source
197723-00-5	CAS Registry Number	ChemIDplus

Last Modified

03 August 2021